In order to strengthen drug quality supervision and ensure the safety of public drug use, local drug regulatory departments are conducting frequent supervision and sampling inspections on the quality of drug production and trading enterprises and drugs used, and issuing announcements
.
In this context, a large number of drugs have been declared unqualified after sampling and need to be rectified
.
It is worth noting that among the many unqualified products, Chinese medicine pieces are undoubtedly the "hardest hit area"
.
The improvement of the quality of traditional Chinese medicine pieces needs to be accelerated, and the upstream pharmaceutical machine industry may be affected (Image source: Pharmaceutical Network)
In many places, the majority of unqualified Chinese medicine pieces accounted for the majority of drug inspections
On December 2, the Yunnan Food and Drug Administration issued a notice on the results of random inspection of drug quality (Issue 4, 2022), involving a total of 3 varieties of non-compliance with the regulations, all of which were traditional Chinese medicine pieces, and the non-conforming items involved were moisture, volatile oil, and microbial limits
.
On October 28, the Guangdong Food and Drug Administration issued a notice on the results of drug quality random inspection (Issue 06, 2022), which involved a total of 1675 batches
of products in this phase of random inspection.
Among them, 4 batches were unqualified, all of which were Chinese medicine pieces, namely red ginseng, cardamom, bran fried potato fruition, and raw ground yellow
.
The unqualified items involved are: determination of residues, properties, moisture and content of other organochlorine pesticides
.
On October 25, the website of the Jiangsu Provincial Drug Administration released a notice on the quality of drugs in Jiangsu Province No.
3 in 2022 (No.
23 of 2022).
Among them, 4 batches did not meet the regulations, these four batches of products were epimedium, wheat dong, peony peel and sand garden, and the unqualified items involved were traits, moisture and impurities
.
On October 13, the Shanghai Food and Drug Administration issued a notice on the results of random inspection of drug quality (Issue 3, 2022), showing that Yinqiao Detoxification Tablets of Aimin Pharmaceutical Group Co.
, Ltd.
, Yuanzhi of Anguo Yuanguang Pharmaceutical Co.
, Ltd.
, and Sanling of Zhejiang Yetongren Pharmaceutical Co.
, Ltd.
, a total of 3 batches of drug sampling did not meet the regulations, and the non-compliant items included aflatoxin, loading differences, and traits
.
.
.
.
.
.
.
In the context of increasingly strict supervision of the Chinese medicine tablet industry, the industry believes that Chinese medicine pieces enterprises need to further strengthen self-discipline, and strictly follow the requirements of the new version of the pharmacopoeia, do a good job in planting, production, processing, circulation and other links to promote the overall quality of the drink piece industry
.
The improvement of Chinese medicine pieces is inseparable from the upstream equipment industry
Due to the advanced pharmaceutical technology and equipment, it will also directly affect the quality and yield
of Chinese medicine pieces.
Therefore, analysts believe that relevant enterprises can also accelerate the standardization of traditional Chinese medicine pieces with the help of more advanced equipment and instruments, and promote the development of
traditional Chinese medicine modernization technology.
It is understood that the current drinking piece machinery includes purification machinery, cutting machinery, cannon moxibustion machinery, material drying machinery, etc.
, and these equipment play an important role
in the processing of drinking pieces.
However, at present, on the whole, the technology and quality level of drinking piece machinery are still difficult to meet the needs of
modern beverage piece production development.
Analysts believe that this is mainly due to the late start of China's traditional Chinese medicine piece machinery industry, the market concentration is not high, and there are many low-level repeated production
.
In order to better ensure the production quality of Chinese medicine pieces, it is necessary to update and upgrade the equipment to further improve product quality control
.
It is reported that the development of the traditional Chinese medicine tablet industry in recent years has actually brought great changes and opportunities
to the pharmaceutical equipment industry.
For example, with the development of automation and digital technology, the pharmaceutical work of Chinese medicine pieces has gradually upgraded to automated and numerical control processing
.
At present, many equipment companies are also accelerating the development
of intelligence, flexibility, precision and production standards.
For example, the high-precision slicer built by a pharmaceutical machine enterprise has greatly improved the degree of automation of the whole machine control, and the cutting accuracy is high, the speed is fast, the feeding is convenient, and the stacking is neat.
There are also pharmaceutical machine enterprises R & D and production of multi-functional traditional Chinese medicine slicer, using fully enclosed design, small size, light weight, easy operation, automatic adjustment of thickness and thickness, favored by the market
.
There are also pharmaceutical enterprises that have built a series of intelligent Chinese medicine pharmaceutical equipment such as a fully intelligent package traceability production line, a fully intelligent Chinese medicine formula granule bottling production line, and a fully intelligent canning packaging line; According to reports, these equipment can reduce work intensity, reduce labor time, and at the same time strengthen the quality of equipment packaging, as well as meet the requirements of
GMP control.
According to the "2021 National Blue Book of Traditional Chinese Medicine Supervision", in recent years, the quality of Chinese medicine pieces has actually improved significantly, from 2016 to 2021, the overall pass rate of Chinese medicine pieces has increased from 77.
7% to 98.
4%.
The industry expects that in the future, with the continuous advancement of centralized procurement policies, the continuous tightening of supervision by relevant departments, and the help of pharmaceutical equipment enterprises, the traditional Chinese medicine tablet industry will embark on a more standardized and high-quality development path
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
